The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma
Abstract
In Brief Background: The Milan criteria have been adopted by United Network for Organ Sharing (UNOS) to preoperatively assess outcome in patients with hepatocellular carcinoma (HCC) who receive orthotopic liver transplantation (OLT). These criteria rely solely on radiographic appearances of the tumor, providing no measure of tumor biology. Recurrence rates, therefore, remain around 20% for patients within the criteria. The neutrophil-lymphocyte ratio (NLR) is an indicator of inflammatory status previously established as a prognostic indicator in colorectal liver metastases. We aimed to determine whether NLR predicts outcome in patients undergoing OLT for HCC. Design: Analysis of patients undergoing OLT for HCC between 2001 and 2007 at our institution. A NLR ≥5 was considered to be elevated. Results: A total of 150 patients were identified, with 13 patients having an elevated NLR. Of these, 62% developed recurrence compared with 14% with normal NLR (P < 0.0001). The disease-free survival for patients with high NLR was significantly worse than that for patients with normal NLR (1-, 3-, and 5-year survivals of 38%, 25%, and 25% vs. 92%, 85%, and 75%, P < 0.0001). Patients with high NLR also had poorer overall survival (5-year survival, 28% vs. 64%, P = 0.001). Patients within Milan with an elevated NLR had significantly poorer disease-free survival than those with normal NLR within Milan (5-year survival, 30% vs. 81%, P < 0.0001). On univariate analysis, 9 factors including an NLR ≥5 were significant predictors of poor disease-free survival. However, only a raised NLR remained significant on multivariate analysis (P = 0.005, HR: 19.98). Conclusion: Elevated NLR significantly increases the risk for tumor recurrence and recipient death. Preoperative NLR measurement may provide a simple method of identifying patients with poorer prognosis and act as an adjunct to Milan in determining, which patients benefit most from OLT. The Milan criteria assess which patients with hepatocellular carcinoma should receive liver transplants. There remains debate as to the utility of these criteria in predicting outcome as they do not include tumor biology measures. We present a novel method of preoperatively assessing outcome in patients with hepatocellular carcinoma who undergo liver transplants, using the neutrophil-lymphocyte ratio. This may act as an important adjunct to these criteria in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Jonas, S., Bechstein, W. O., Steinmüller, T., Herrmann, M., Radke, C., Berg, T., Settmacher, U., & Neuhaus, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23561 · Cited by 894
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
Walsh, S. R., Cook, E. J., Goulder, F., Justin, T. A., & Keeling, N. J. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20329 · Cited by 894
Identification of metastasis-related microRNAs in hepatocellular carcinoma
Budhu, A., Jia, H.-L., Forgues, M., Liu, C.-G., Goldstein, D., Lam, A., Zanetti, K. A., Ye, Q.-H., Qin, L.-X., Croce, C. M., et al. (2008) · Hepatology · doi:10.1002/hep.22160 · Cited by 697
The codependence of angiogenesis and chronic inflammation
Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 694
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
IWATSUKI, S., STARZL, T. E., SHEAHAN, D. G., YOKOYAMA, I., DEMETRIS, A. J., TODO, S., TZAKIS, A. G., VAN THIEL, D. H., CARR, B., SELBY, R., et al. (1991) · Annals of Surgery · doi:10.1097/00000658-199109000-00005 · Cited by 669
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Ringe, B., Pichlmayr, R., Wittekind, C., & Tusch, G. (1991) · World Journal of Surgery · doi:10.1007/bf01659064 · Cited by 565
Kusumanto, Y. H., Dam, W. A., Hospers, G. A. P., Meijer, C., & Mulder, N. H. (2003) · Angiogenesis · doi:10.1023/b:agen.0000029415.62384.ba · Cited by 530
Systemic inflammatory response predicts survival following curative resection of colorectal cancer
McMillan, D. C., Canna, K., & McArdle, C. S. (2003) · British Journal of Surgery · doi:10.1002/bjs.4038 · Cited by 454
Duffy, J. P., Vardanian, A., Benjamin, E., Watson, M., Farmer, D. G., Ghobrial, R. M., Lipshutz, G., Yersiz, H., Lu, D. S. K., Lassman, C., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318148c704 · Cited by 445
Halazun, K. J., Aldoori, A., Malik, H. Z., Al-Mukhtar, A., Prasad, K. R., Toogood, G. J., & Lodge, J. P. A. (2008) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2007.02.014 · Cited by 444
Self-citationGomez, D., Farid, S., Malik, H. Z., Young, A. L., Toogood, G. J., Lodge, J. P. A., & Prasad, K. R. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9552-6 · Cited by 402
Sumie, S., Kuromatsu, R., Okuda, K., Ando, E., Takata, A., Fukushima, N., Watanabe, Y., Kojiro, M., & Sata, M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9846-9 · Cited by 386
Llovet, J. M., Bruix, J., Fuster, J., Castells, A., Garcia-Valdecasas, J. C., Grande, L., França, A., Brú, C., Navasa, M., Ayuso, M. D., et al. (1998) · Hepatology · doi:10.1002/hep.510270616 · Cited by 382
Liver Transplantation for Hepatocellular Carcinoma
Hemming, A. W., Cattral, M. S., Reed, A. I., Van der Werf, W. J., Greig, P. D., & Howard, R. J. (2001) · Annals of Surgery · doi:10.1097/00000658-200105000-00009 · Cited by 311
Figueras, J., Jaurrieta, E., Valls, C., Benasco, C., Rafecas, A., Xiol, X., Fabregat, J., Casanovas, T., Torras, J., Baliellas, C., et al. (1997) · Hepatology · doi:10.1002/hep.510250629 · Cited by 271
Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T‐regulatory cells†‡
Unitt, E., Rushbrook, S. M., Marshall, A., Davies, S., Gibbs, P., Morris, L. S., Coleman, N., & Alexander, G. J. M. (2005) · Hepatology · doi:10.1002/hep.20644 · Cited by 267
Unitt, E., Marshall, A., Gelson, W., Rushbrook, S. M., Davies, S., Vowler, S. L., Morris, L. S., Coleman, N., & Alexander, G. J. M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.027 · Cited by 257
Chao, Y., Li, C.-P., Chau, G.-Y., Chen, C.-P., King, K.-L., Lui, W.-Y., Yen, S.-H., Chang, F.-Y., Chan, W.-K., & Lee, S.-D. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.10.002 · Cited by 209
A Prospective Study of Serum C-Reactive Protein and Colorectal Cancer Risk in Men
Gunter, M. J., Stolzenberg-Solomon, R., Cross, A. J., Leitzmann, M. F., Weinstein, S., Wood, R. J., Virtamo, J., Taylor, P. R., Albanes, D., & Sinha, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3631 · Cited by 205
Malik, H. Z., Prasad, K. R., Halazun, K. J., Aldoori, A., Al-Mukhtar, A., Gomez, D., Lodge, J. P. A., & Toogood, G. J. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318142d964 · Cited by 204
Self-citationTanigawa, N., Amaya, H., Matsumura, M., & Shimomatsuya, T. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.826 · Cited by 172
McMillan, D. C., Wotherspoon, H., Fearon, K. C. H., Sturgeon, C., Cooke, T. G., & McArdle, C. S. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80296-7 · Cited by 153
Vivarelli, M., Bellusci, R., Cucchetti, A., Cavrini, G., Ruvo, N. D., Aden, A. A., Barba, G. L., Brillanti, S., & Cavallari, A. (2002) · Transplantation · doi:10.1097/00007890-200212270-00017 · Cited by 150
The risk of tumoral seeding in needle biopsies.
Roussel, F., Dalion, J., & Benozio, M. (1989) · PubMed · Cited by 108
Serum C‐reactive protein levels predict survival in hepatocellular carcinoma
Nagaoka, S., Yoshida, T., Akiyoshi, J., Akiba, J., Torimura, T., Adachi, H., Kurogi, J., Tajiri, N., Inoue, K., Niizeki, T., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01550.x · Cited by 100
Fenwick, S. W., Toogood, G. J., Lodge, J. P. A., & Hull, M. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01061-8 · Cited by 88
Freise, C. E., Ferrell, L. D., Liu, T., Ascher, N. L., & Roberts, J. P. (1999) · Transplantation · doi:10.1097/00007890-199902270-00003 · Cited by 85
Lymphocytic infiltration surrounding liver metastases from colorectal cancer
Okano, K., Maeba, T., Moroguchi, A., Ishimura, K., Karasawa, Y., Izuishi, K., Goda, F., Usuki, H., Wakabayashi, H., & Maeta, H. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10188 · Cited by 69
Vascular density and VEGF expression in hepatic lesions.
Brodsky, S. V., Mendelev, N., Melamed, M. R., & Ramaswamy, G. (2007) · PubMed · Cited by 60
Moreno, P., Jaurrieta, E., Figueras, J., et al. (1995) · PubMed · Cited by 41
Baek, J. Y., Hur, W., Wang, J. S., Bae, S. H., & Yoon, S. K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i8.1175 · Cited by 35
Cited by
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
“Lymphocytes play a crucial role in tumor defense by inducing cytotoxic cell death and inhibiting tumor cell proliferation and migration (16), thereby dictating the host immune response to malignancy (12).”
BackgroundThe systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552
de Jager, C. P., van Wijk, P. T., Mathoera, R. B., de Jongh-Leuvenink, J., van der Poll, T., & Wever, P. C. (2010) · Critical Care · doi:10.1186/cc9309 · Cited by 672
Azab, B., Bhatt, V. R., Phookan, J., Murukutla, S., Kohn, N., Terjanian, T., & Widmann, W. D. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1814-0 · Cited by 565
Chua, W., Charles, K. A., Baracos, V. E., & Clarke, S. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.100 · Cited by 468
Metadata
- Authors
- Halazun, K. J., Hardy, M. A., Rana, A. A., Woodland, D. C., Luyten, E. J., Mahadev, S., Witkowski, P., Siegel, A. B., Brown, R. S., & Emond, J. C.
- Venue
- Annals of Surgery
- Published
- 2009-07
- Volume
- 250
- Issue
- 1
- Pages
- 141-151
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2005041705
- Cited by
- 401
- References
- 38
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.